Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.


Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence


Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
Needmore seats to Win
Needmore seats to Win
2-min read

Fortis Healthcare Promoters Malvinder, Shivinder Singh Resign From Board

"Malvinder Mohan Singh, Executive Chairman and Shivinder Mohan Singh, Non-Executive Vice Chairman have tendered their resignation from the directorships of the company," Fortis Healthcare said.


Updated:February 9, 2018, 12:44 PM IST
Fortis Healthcare Promoters Malvinder, Shivinder Singh Resign From Board
File photo of Malvinder Singh and Shivinder Singh. (Courtesy: Reuters)
New Delhi: Fortis Healthcare promoters Malvinder Mohan Singh and Shivinder Mohan Singh have resigned as directors from the company's board following the Delhi High Court order upholding the Rs 35-billion arbitral award in favour of Daiichi Sankyo.

The Singh brothers have jointly tendered their resignation to the Board of Fortis Healthcare, which will discuss it in the meeting on February 13, the company said in a filing to the BSE.

"Malvinder Mohan Singh, Executive Chairman and Shivinder Mohan Singh, Non-Executive Vice Chairman have tendered their resignation from the directorships of the company," Fortis Healthcare said.

The resignation is intended to free the organisation from any encumbrances that may be linked to the promoters, the letter said.

"In light of the recent High Court judgement upholding the plea of Daiichi Sankyo to enforce the arbitration award, we believe this is in the interest of propriety and good governance," it said.

The Delhi High Court had on January 31 upheld an international arbitral award of Rs 35 billion passed in favour of Japanese pharma major Daiichi Sankyo, which has alleged that the former promoters of India's Ranbaxy Laboratories had concealed information about proceedings against them by American food and drug department.

A tribunal in Singapore had passed the verdict in favour of Daiichi holding that the former Ranbaxy promoters and brothers, Malvinder Singh and Shivinder Singh, had concealed information that the Indian company was facing probe by the US Food and Drug Administration and the Department of Justice, while selling its shares.

With the resignation of the promoters, the board will be "better enabled and empowered to guide the future direction of the organisation without anyway being hampered by the Daiichi Sankyo judgement and our association at the Board," the letter said.

"The members of the board are also requested to look into all inter-group transactions and distance the promoter group from Fortis Healthcare Ltd in a manner that enables continuity of the operations of the organisation and deliver on its mission of enriching and saving lives," the Singh brothers wrote in the letter.

The high court order paved the way for enforcement of the 2016 arbitral award passed by the Singapore tribunal against the Singh brothers who had sold their shares in Ranbaxy to Daiichi in 2008 for Rs 95.76 billion.

Sun Pharmaceuticals Ltd later acquired the company from Daiichi.

Daiichi had approached the high court in 2016 to seek the enforcement of a Rs 25.62 billion Singapore arbitral award passed in April 2016, along with an additional claim of interest and lawyers' fees incurred in connection with the proceedings.

The tribunal's award had come after the Japanese company invoked arbitration clause against Singhs alleging that they concealed important information while selling Ranbaxy in 2008.

Daiichi had entered into a settlement agreement with the US Department of Justice, agreeing to pay $500 million penalty to resolve potential, civil and criminal liability.

The company had then sold its stake in Ranbaxy to Sun Pharmaceuticals for Rs 226.79 billion in 2015.
(Get detailed and live results of each and every seat in the Lok Sabha elections and state Assembly elections in Andhra Pradesh, Odisha, Arunachal Pradesh and Sikkim to know which candidate/party is leading or trailing and to know who has won and who has lost and by what margin. Our one-of-its-kind Election Analytics Centre lets you don a psephologist’s hat and turn into an election expert. Know interesting facts and trivia about the elections and see our informative graphics. Elections = News18)
| Edited by: Huma Tabassum
Read full article
Next Story
Next Story

Also Watch

Most Active
Company Price Change %Gain
SBI 347.85 1.98
Reliance 1,349.00 0.64
IndusInd Bank 1,598.35 5.23
HDFC Bank 2,357.65 -2.00
ICICI Bank 418.20 3.17
Company Price Change %Gain
Reliance 1,350.25 0.71
Larsen 1,487.40 1.84
SBI 348.15 2.14
Yes Bank 141.75 2.94
Adani Enterpris 170.90 8.20
Top Gainers
Company Price Change %Gain
Adani Ports 410.05 6.24
IndusInd Bank 1,598.40 5.23
Grasim 901.00 5.09
Zee Entertain 358.45 4.75
ICICI Bank 418.20 3.17
Company Price Change %Gain
IndusInd Bank 1,599.60 5.41
ICICI Bank 417.65 3.00
Yes Bank 141.75 2.94
Hero Motocorp 2,768.05 2.57
Bharti Airtel 342.35 2.18
Top Losers
Company Price Change %Gain
Vedanta 160.55 -3.46
ITC 290.10 -3.22
Eicher Motors 20,603.00 -2.93
HDFC Bank 2,357.65 -2.00
Bajaj Finserv 8,098.15 -1.50
Company Price Change %Gain
Vedanta 160.70 -3.45
ITC 290.35 -3.07
HDFC Bank 2,358.40 -1.94
TCS 2,057.75 -1.20
Bajaj Finance 3,411.75 -1.04

Live TV

Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results